NinePointTwo Capital’s Medtronic MDT Stock Holding History

NinePointTwo Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$316K	Hold	3,841	–	–	0.13%	114
2023 Q3	$300K	Hold	3,841	–	–	0.12%	48
2023 Q2	$338K	Hold	3,841	–	–	0.13%	44
2023 Q1	$309K	Hold	3,841	–	–	0.12%	41
2022 Q4	$298K	Sell	3,841 -2,224	-37%	-$180K	0.12%	40
2022 Q3	$489K	Sell	6,065 -576	-9%	-$51.8K	0.2%	29
2022 Q2	$596K	Buy	6,641 +2,080	+46%	+$211K	0.21%	26
2022 Q1	$506K	Hold	4,561	–	–	0.14%	41
2021 Q4	$471K	Buy	4,561 +2,699	+145%	+$313K	0.15%	32
2021 Q3	$233K	Sell	1,862 -1,136	-38%	-$147K	0.09%	42
2021 Q2	$372K	Buy	2,998 +1,136	+61%	+$143K	0.13%	40
2021 Q1	$219K	Hold	1,862	–	–	0.08%	51
2020 Q4	$218K	Buy	+1,862	New	+$205K	0.09%	49

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NinePointTwo Capital's MDT Position: Q4 2023 in Review

NinePointTwo Capital held its Medtronic (MDT) position steady in Q4 2023 at 3,841 shares worth $316K. The position accounts for 0.13% of the portfolio, ranked #114.

NinePointTwo Capital first reported a position in MDT in Q4 2020 and has held it in 13 quarters since. The position peaked at $596K in Q2 2022. 2,074 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

NinePointTwo Capital held 3,841 shares of Medtronic worth $316K as of Q4 2023.
NinePointTwo Capital left its Medtronic share count unchanged in Q4 2023.
Medtronic made up 0.13% of NinePointTwo Capital's portfolio in Q4 2023, its #114 holding.
NinePointTwo Capital first reported a position in Medtronic in Q4 2020 and has held it in 13 quarters since.
NinePointTwo Capital's Medtronic position peaked at $596K in Q2 2022.
2,074 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on NinePointTwo Capital's 13F filing for Q4 2023, filed 14 Feb 2024.